miR-126 in human cancers: clinical roles and current perspectives (Q38173789)

30 August 2017

title

miR-126 in human cancers: clinical roles and current perspectives (English)

1 reference

30 August 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24368110 AND SRC:MED&resulttype=core&format=json

12 June 2020

Alfred King-Yin Lam

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24368110 AND SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Faeza Ebrahimi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24368110 AND SRC:MED&resulttype=core&format=json

12 June 2020

Robert Anthony Smith

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24368110 AND SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

22 December 2013

1 reference

Experimental and Molecular Pathology

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24368110 AND SRC:MED&resulttype=core&format=json

12 June 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24368110 AND SRC:MED&resulttype=core&format=json

12 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24368110 AND SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

98-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24368110 AND SRC:MED&resulttype=core&format=json

miRNAs in colon and rectal cancer: A consensus for their true clinical value

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNAs are novel biomarkers of colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Deregulated expression of miR-106a predicts survival in human colon cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MiRNA genes constitute new targets for microsatellite instability in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

miR-126 functions as a tumour suppressor in human gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

miR-126 regulates angiogenic signaling and vascular integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Accurate molecular classification of renal tumors using microRNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Prognostic significance of differentially expressed miRNAs in esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talks confers angiogenesis of cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Expression Profiling of Difficult-to-diagnose Thyroid Histologic Subtypes Shows Distinct Expression Profiles and Identify Candidate Diagnostic microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Identification of tissue-specific microRNAs from mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Altered JS‐2 expression in colorectal cancers and its clinical pathological relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Survival prediction of gastric cancer by a seven-microRNA signature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Down-regulation of miR-126 expression in colorectal cancer and its clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Differential expression of miRNAs in esophageal cancer tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

miR-126 and miR-126*: New Players in Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Molecular Classification of Adult Renal Epithelial Neoplasms Using MicroRNA Expression and Virtual Karyotyping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Treatment-independent miRNA signature in blood of Wilms tumor patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNA-126 regulates HOXA9 by binding to the homeobox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Endogenous human microRNAs that suppress breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNAs Associated with Metastatic Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Irinotecan and colorectal cancer: the role of p53, VEGF-C and alpha-B-crystallin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Accurate molecular classification of kidney cancer subtypes using microRNA signature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

The cell growth suppressor, mir-126, targets IRS-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004

miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YEXMP.2013.12.004